Track the サワイグループホールディングス株式会社 stock price and the full management transaction log of the company, a publicly traded company based in Japan. Shares are quoted on JP JP, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, サワイグループホールディングス株式会社 has recorded 40 public disclosures. Market capitalisation: €194.1bn. The latest transaction was filed on 22 July 2026 (Holding update). Among the most active insiders: JPMorgan Asset Management (Japan) Limited. The full history is openly available.
40
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate サワイグループホールディングス株式会社 Buy (bullish), based on 9 analysts. Average price target: JP¥2,294.
23Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 16,468 of 28,205 companies
47.1
score / 100
Value
50
Quality
44
FCF yld-9.3%
Earn yld5.7%
EV/EBITDA9.0x
ROE6.5%
Gross mgn29%
Net mgn5.2%
Debt/EBITDA3.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Sawai Group Holdings Co., Ltd. is a Japanese company operating in the healthcare and pharmaceutical sector. It is listed on the Tokyo Stock Exchange under the symbol XTKS.